The Effect of XP-Endo Finisher Activation of Bioceramic Sealer on Postoperative Pain in Mandibular First Molar With Symptomatic Irreversible Pulpitis

Launched by FUTURE UNIVERSITY IN EGYPT · Oct 10, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how the use of a special device called the XP-Endo Finisher affects pain after root canal treatment for patients with a specific dental condition called symptomatic irreversible pulpitis. The goal is to see if activating a bioceramic sealer with this device helps reduce pain in patients who have severe tooth pain in their lower jaw's first molar. The trial involves 30 participants, divided into two groups: one group will receive the treatment with the XP-Endo Finisher, while the other group will receive the bioceramic sealer without the activation.

To be eligible for this study, participants must be between 18 and 40 years old and have a healthy medical history. They should be experiencing sharp pain in a lower first molar tooth that still has vital (living) pulp tissue. Participants will be asked to understand a simple pain rating scale and provide consent to join the trial. If you are pregnant, have certain health conditions, or have taken specific medications recently, you may not be able to participate. Those who join can expect to undergo root canal treatment and be monitored for any changes in pain afterward. This trial is important as it could lead to better pain management techniques during dental procedures.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ranges from 18 to 40 years old.
• • No sex predilection.
• • Patients seeking root canal treatment.
• • Systematically healthy patient (ASA I, II).
• • Patient who can understand numerical rate scale and sign an informed consent.
• * Mandibular first molar teeth with:
• • Preoperative sharp (moderate or severe) pain.
• • Vital response of pulp tissue to cold pulp tester (ethyl chloride spray).
• • Normal periapical radiographic appearance.
• Exclusion Criteria:
• • Patients with American association of anesthesiologists (ASA) classification other than ASA T\& II.
• • Patients who have already ingested preoperative medication, such as analgesics, non-steroidal or steroidal anti-inflammatory drugs, within 12 hours of the start of treatment.
• • Patients with NSAIDs allergy.
• • Patients having two or more adjacent teeth needing root canal therapy.
• • Pregnant patients.
• • Patients with bleeding disorder.
• • Patients with long term corticosteroid use
• • Teeth having;
• • Necrotic pulp.
• • History or presence of swelling or fistulous tract.
• • Acute / chronic periapical abscess.
• • Mobility more than grade 1.
• • Pocket depth more than 5mm.
• • No possible restorability.
• • Previous root canal treatment.
• • Periapical radiolucency.
• • External or internal resorption.
• • Vertical root fracture.
• • TMJ problems, bruxism, clenching or traumatic occlusion.
• • Inability to understand and perform the given instructions.